Charles River Laboratories | CRL - Passivo Circulante

Preço das Ações
169.80
Mudança Diária
2.06 1.23%
Mensal
2.36%
Anual
48.09%
Q2 Previsão
166.17




Passivo Circulante Alterar Data
Agilent USD 2.23B 113M 2025-12
Align Technology USD 1.92B 46.45M 2025-12
Bio-Rad Laboratories USD 517M 5.3M 2025-12
Bruker USD 1.28B 11.1M 2025-12
Cardinal Health USD 43.31B 3.05B 2025-12
Charles River Laboratories USD 1.12B 1.57M 2025-12
Cigna USD 56.34B 111M 2025-12
Concord Medical Services Hldg CNY 2.45B 1.12B 2025-06
CVS Health USD 88.69B 4B 2025-12
Danaher USD 7.46B 653M 2026-03
Dentsply International USD 1.34B 62M 2025-12
Elevance Health USD 45.31B 4.27B 2026-03
Galapagos EUR 152.86M 213.7M 2025-12
Humana USD 16.35B 166M 2025-12
Illumina USD 1.59B 377M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Intrexon USD 23.02M 38K 2024-06
IQVIA Holdings USD 8.34B 170M 2025-12
Laboratory Of America USD 2.82B 194.3M 2025-12
Lonza CHF 3.57B 421M 2025-12
McKesson USD 68.13B 100M 2025-12
Merck EUR 9.04B 405M 2025-12
Mettler Toledo International USD 1.2B 5.99M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Quest Diagnostics USD 2.18B 101M 2026-03
Revvity USD 1.33B 108.5M 2025-12
Thermo Fisher Scientific USD 14.62B 568M 2026-03
United Therapeutics USD 560.6M 14.3M 2025-12
UnitedHealth USD 114.9B 629M 2025-12
Veradigm USD 230.31M 22.78M 2022-12
Waters USD 1.24B 11.8M 2025-12
West Pharmaceutical Services USD 674M 19.1M 2026-03